PKvitality enters into a key partnership with Beurer Gmbh



We have entered into a key partnership with Beurer Gmbh, one of the top 3 distributors of Blood Glucose meters in Germany, Austria, and Italy.

After extensive due diligence, Beurer decided to invest 2m€ (out of a global investment of 2.25m€) to help further develop the K’Watch and begin human clinical trials. They have acquired exclusive commercialization rights in Germany, Austria, and Italy.

Patient-friendly and cost-effective, Beurer believes that K’Watch will become a leading product to measure blood glucose levels in real-time.

According to Marco Bühler, Managing Director of Beurer Gmbh, ” PKvitality has one of the strongest teams and technology portfolio in the area of future Glucose monitoring applied to Continuous Glucose Monitoring. The concept of realizing a CGM in a smartwatch that is basically pain-free and non-stigmatizing in combination with a much more cost-efficient sensor patch is convincing. We are looking forward to launching the K’Watch in our key territories, and are convinced that this patient-friendly and the cost-effective device will meet a large success”

If you are interested in investing in PKvitality, you can meet us at the Biotech and Medtech showcase, a satellite event to JP Morgan Healthcare Conference, from 13th to 15th January 2020 in San Francisco, California, or send inquiries to

Read the full press release here

You might also like: